Understanding the 30-day mortality burden after revision total knee arthroplasty

Background: In revision total knee arthroplasty (TKA), information regarding perioperative mortality risk is essential for careful decision-making. This study aimed to elucidate the (1) overall 30-day mortality rate and (2) 30-day mortality rate stratified by age, comorbidity, and septic vs aseptic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: SaTia T. Sinclair, DO, MPH, Melissa N. Orr, BS, Christopher A. Rothfusz, BS, Alison K. Klika, MS, John P. McLaughlin, DO, Nicolas S. Piuzzi, MD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/ff27fd0d7cdf4e5691bb081c614780ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ff27fd0d7cdf4e5691bb081c614780ad
record_format dspace
spelling oai:doaj.org-article:ff27fd0d7cdf4e5691bb081c614780ad2021-11-14T04:34:07ZUnderstanding the 30-day mortality burden after revision total knee arthroplasty2352-344110.1016/j.artd.2021.08.019https://doaj.org/article/ff27fd0d7cdf4e5691bb081c614780ad2021-10-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352344121001606https://doaj.org/toc/2352-3441Background: In revision total knee arthroplasty (TKA), information regarding perioperative mortality risk is essential for careful decision-making. This study aimed to elucidate the (1) overall 30-day mortality rate and (2) 30-day mortality rate stratified by age, comorbidity, and septic vs aseptic failure after revision TKA. Methods: The American College of Surgeons National Surgical Quality Improvement Program was reviewed for all patients undergoing revision TKA from 2011 to 2019. A total of 32,354 patients who underwent TKA were identified and categorized as mortality (n = 115) or mortality-free (n = 32,239). Patient characteristics were compared between cohorts and further stratified by septic and aseptic failure. Results: The overall 30-day mortality rate was 0.36%. The percentage of deaths per age group (normalized per 1000) was 0% (18-29 years), 0% (30-39 years), 0.18% (40-49 years), 0.13% (50-59 years), 0.14% (60-69 years), 0.40% (70-79 years), 1.25% (80-89 years), and 6.93% (90+ years). The percentage of deaths per American Society of Anesthesiologists (ASA) class was 0.30% (ASA 1), 0.06% (ASA 2), 0.39% (ASA 3), 2.41% (ASA 4), and 14.29% (ASA 5). Septic revision (P < .001), general anesthesia (P < .001), body mass index ≤ 24.9 (P < .001), and insulin-dependent diabetes (P = .039) were associated with an increased risk of mortality. Conclusions: Increasing age, greater comorbidity burden, underweight or normal body mass index, insulin-dependent diabetes, septic revision, and general anesthesia were all associated with an increased risk of mortality after revision TKA. Notably, 1 in 80 patients aged 80-89 years died after revision TKA compared to 1 in 720 patients aged 60-69 years. Patients who underwent septic revision had a 4-fold increase in mortality compared to aseptic revision. Our stratified assessment of mortality provides a more individualized estimation of risk that can be used for patient counseling in revision TKA.SaTia T. Sinclair, DO, MPHMelissa N. Orr, BSChristopher A. Rothfusz, BSAlison K. Klika, MSJohn P. McLaughlin, DONicolas S. Piuzzi, MDElsevierarticleRevision total knee arthroplastyTotal knee arthroplastyMortalityRisk assessmentOrthopedic surgeryRD701-811ENArthroplasty Today, Vol 11, Iss , Pp 205-211 (2021)
institution DOAJ
collection DOAJ
language EN
topic Revision total knee arthroplasty
Total knee arthroplasty
Mortality
Risk assessment
Orthopedic surgery
RD701-811
spellingShingle Revision total knee arthroplasty
Total knee arthroplasty
Mortality
Risk assessment
Orthopedic surgery
RD701-811
SaTia T. Sinclair, DO, MPH
Melissa N. Orr, BS
Christopher A. Rothfusz, BS
Alison K. Klika, MS
John P. McLaughlin, DO
Nicolas S. Piuzzi, MD
Understanding the 30-day mortality burden after revision total knee arthroplasty
description Background: In revision total knee arthroplasty (TKA), information regarding perioperative mortality risk is essential for careful decision-making. This study aimed to elucidate the (1) overall 30-day mortality rate and (2) 30-day mortality rate stratified by age, comorbidity, and septic vs aseptic failure after revision TKA. Methods: The American College of Surgeons National Surgical Quality Improvement Program was reviewed for all patients undergoing revision TKA from 2011 to 2019. A total of 32,354 patients who underwent TKA were identified and categorized as mortality (n = 115) or mortality-free (n = 32,239). Patient characteristics were compared between cohorts and further stratified by septic and aseptic failure. Results: The overall 30-day mortality rate was 0.36%. The percentage of deaths per age group (normalized per 1000) was 0% (18-29 years), 0% (30-39 years), 0.18% (40-49 years), 0.13% (50-59 years), 0.14% (60-69 years), 0.40% (70-79 years), 1.25% (80-89 years), and 6.93% (90+ years). The percentage of deaths per American Society of Anesthesiologists (ASA) class was 0.30% (ASA 1), 0.06% (ASA 2), 0.39% (ASA 3), 2.41% (ASA 4), and 14.29% (ASA 5). Septic revision (P < .001), general anesthesia (P < .001), body mass index ≤ 24.9 (P < .001), and insulin-dependent diabetes (P = .039) were associated with an increased risk of mortality. Conclusions: Increasing age, greater comorbidity burden, underweight or normal body mass index, insulin-dependent diabetes, septic revision, and general anesthesia were all associated with an increased risk of mortality after revision TKA. Notably, 1 in 80 patients aged 80-89 years died after revision TKA compared to 1 in 720 patients aged 60-69 years. Patients who underwent septic revision had a 4-fold increase in mortality compared to aseptic revision. Our stratified assessment of mortality provides a more individualized estimation of risk that can be used for patient counseling in revision TKA.
format article
author SaTia T. Sinclair, DO, MPH
Melissa N. Orr, BS
Christopher A. Rothfusz, BS
Alison K. Klika, MS
John P. McLaughlin, DO
Nicolas S. Piuzzi, MD
author_facet SaTia T. Sinclair, DO, MPH
Melissa N. Orr, BS
Christopher A. Rothfusz, BS
Alison K. Klika, MS
John P. McLaughlin, DO
Nicolas S. Piuzzi, MD
author_sort SaTia T. Sinclair, DO, MPH
title Understanding the 30-day mortality burden after revision total knee arthroplasty
title_short Understanding the 30-day mortality burden after revision total knee arthroplasty
title_full Understanding the 30-day mortality burden after revision total knee arthroplasty
title_fullStr Understanding the 30-day mortality burden after revision total knee arthroplasty
title_full_unstemmed Understanding the 30-day mortality burden after revision total knee arthroplasty
title_sort understanding the 30-day mortality burden after revision total knee arthroplasty
publisher Elsevier
publishDate 2021
url https://doaj.org/article/ff27fd0d7cdf4e5691bb081c614780ad
work_keys_str_mv AT satiatsinclairdomph understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty
AT melissanorrbs understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty
AT christopherarothfuszbs understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty
AT alisonkklikams understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty
AT johnpmclaughlindo understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty
AT nicolasspiuzzimd understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty
_version_ 1718429996320555008